Results 141 to 150 of about 24,077 (195)
Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms. [PDF]
Curr Hematol Malig RepHanna C +4 more
europepmc +1 more source
Abnormal Eosinophils With Large, Distinctly Basophilic Granules (Harlequin Cells) on Peripheral Blood Smear: A Clue for Diagnosing Chronic Myeloid Leukemia. [PDF]
J HematolCai J, Yue C, Tomassetti S.
europepmc +1 more source
Cutaneous Extramedullary Hematopoiesis in Primary Myelofibrosis: A Case Report With Rapidly Fatal Outcome. [PDF]
CureusEl Bouhmadi A +4 more
europepmc +1 more source
Correction to: Surgical management of giant splenomegaly in chronic myeloid leukemia: a challenging splenectomy case. [PDF]
J Surg Case Repeuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematology/Oncology Clinics of North America, 2014
The emergency providers generally encounters myeloproliferative disorders (MPNs) in 1 of 2 ways: as striking laboratory abnormalities of seeming unknown consequence, or in previously diagnosed patients presenting with complications. The course of patients with MPNs is highly variable, but major complications can arise.
Brian, Meier, John H, Burton
openaire +3 more sources
The emergency providers generally encounters myeloproliferative disorders (MPNs) in 1 of 2 ways: as striking laboratory abnormalities of seeming unknown consequence, or in previously diagnosed patients presenting with complications. The course of patients with MPNs is highly variable, but major complications can arise.
Brian, Meier, John H, Burton
openaire +3 more sources
Best Practice & Research Clinical Haematology, 2001
The myeloproliferative disorders (MPDs) are a group of pre-leukaemic disorders characterized by proliferation of one or more lineages of the myelo-erythroid series. Unlike the Philadelphia chromosome in chronic myeloid leukaemia, there is no pathognomonic chromosomal abnormality associated with the MPDs.
Bench, Anthony J. +4 more
openaire +3 more sources
The myeloproliferative disorders (MPDs) are a group of pre-leukaemic disorders characterized by proliferation of one or more lineages of the myelo-erythroid series. Unlike the Philadelphia chromosome in chronic myeloid leukaemia, there is no pathognomonic chromosomal abnormality associated with the MPDs.
Bench, Anthony J. +4 more
openaire +3 more sources